First Treatment Approved for the Rare Disease in Which Antibodies Destroy a Patient's Own Red Blood Cells
FDA approved Imaavy for warm autoimmune hemolytic anemia in patients 12 and older, the first therapy proven safe and effective for the disease.
Medical Daily ·